EGFR and non-small cell lung carcinoma: It was found that in NSCLC, EGFR-TKIs, chemotherapy, EGFR-positive, and EGFR-wildtype groups, the median OS of the low Ki-67 expression group was significantly longer than that of the high Ki-67 expression group.